Jump to main content
Jump to site search

Issue 7, 2017
Previous Article Next Article

Proteomic analysis of prognostic plasma biomarkers in peripheral arterial occlusive disease

Author affiliations

Abstract

Peripheral arterial occlusive disease (PAOD), one of the major manifestations of systemic atherosclerosis, causes intermittent claudication and rest pain. Patients with PAOD not only have reduced quality of life, but also have a substantial risk of cardiovascular morbidity and death. In this study, we adopted a proteomics-based approach using 2D-DIGE and MALDI-TOF MS to compare the differential plasma proteome between good and poor prognosis of PAOD. We identified 196 plasma proteins, which represent 42 unique gene products. These proteins mainly have roles in the inflammatory response and coagulation. This approach identified several potential prognostic plasma markers in PAOD, including transthyretin and complement factor B, which may be associated with the evaluation of good/poor prognosis of PAOD. In conclusion, we report a comprehensive patient-based plasma proteomic approach for the identification of potential plasma biomarkers for the screening and detection of good/poor prognosis of PAOD. Among these, transthyretin and complement factor B are potential markers for monitoring the PAOD disease in the plasma.

Graphical abstract: Proteomic analysis of prognostic plasma biomarkers in peripheral arterial occlusive disease

Back to tab navigation

Supplementary files

Publication details

The article was received on 17 Apr 2017, accepted on 09 May 2017 and first published on 10 May 2017


Article type: Paper
DOI: 10.1039/C7MB00229G
Citation: Mol. BioSyst., 2017,13, 1297-1303
  •   Request permissions

    Proteomic analysis of prognostic plasma biomarkers in peripheral arterial occlusive disease

    C. Yang, Y. Wei, H. Tsai, I. Cheong, S. Chang, H. Chou, Y. Lee and H. Chan, Mol. BioSyst., 2017, 13, 1297
    DOI: 10.1039/C7MB00229G

Search articles by author

Spotlight

Advertisements